They found relations between the levels of PRB2, SERPINA1, Elastase 3A, CystD, and CELA3B expression in GC progression (4) They believed that three-biomarker panel of CystD+PepA-Ela3A could be sufficient for GC diagnosis with 95.7% sensitivity. The gene discussed is CNDP2; the disease is gastric cancer.